本文選題：人類胚胎干細(xì)胞 + 人類胚胎干細(xì)胞發(fā)明��； 參考：《華中科技大學(xué)》2012年碩士論文

【摘要】：目前，世界上很多國家都鼓勵(lì)和支持人類胚胎干細(xì)胞的研究，，但大多數(shù)國家都對(duì)人類胚胎干細(xì)胞的可專利性問題采取否定的態(tài)度，其理由主要是基于倫理道德的考慮。但是隨著科學(xué)技術(shù)的不斷發(fā)展，傳統(tǒng)專利制度所保護(hù)的客體范圍受到了挑戰(zhàn)。在生物技術(shù)領(lǐng)域，人類胚胎干細(xì)胞技術(shù)的快速發(fā)展和其極大的醫(yī)療價(jià)值引起了人們極大的關(guān)注。由于人類胚胎干細(xì)胞發(fā)明被排除在專利保護(hù)之外，許多新的人類胚胎干細(xì)胞技術(shù)不能得到專利制度的保護(hù)。將人類胚胎干細(xì)胞發(fā)明完全排除在專利保護(hù)之外將隨著人類胚胎干細(xì)胞技術(shù)的發(fā)展受到越來越大的挑戰(zhàn)，實(shí)務(wù)中也陸續(xù)出現(xiàn)了關(guān)于人類胚胎干細(xì)胞發(fā)明可專利性的案例，這些案例的出現(xiàn)也引發(fā)了強(qiáng)烈的理論和實(shí)務(wù)上的爭(zhēng)議。因此我們有必要重新審視關(guān)于人類胚胎干細(xì)胞發(fā)明可專利性的問題。 本文首先介紹了胚胎干細(xì)胞的基本知識(shí)，并概括出人類胚胎干細(xì)胞發(fā)明可專利性的障礙所在；然后對(duì)人類胚胎干細(xì)胞研究行為的法律管制現(xiàn)狀和專利保護(hù)現(xiàn)狀進(jìn)行總結(jié)述評(píng)，以觀察各國對(duì)于人類胚胎干細(xì)胞研究的態(tài)度；接著分別從可專利主題和實(shí)質(zhì)授權(quán)要件兩個(gè)方面對(duì)人類胚胎干細(xì)胞發(fā)明的可專利性進(jìn)行分析，得出了人類胚胎干細(xì)胞發(fā)明專利保護(hù)可行的結(jié)論；最后對(duì)我國現(xiàn)有專利制度對(duì)于人類胚胎干細(xì)胞發(fā)明的適用進(jìn)行分析，并提出相關(guān)建議。
[Abstract]:At present, many countries in the world have encouraged and supported the research of human embryonic stem cells, but most countries take a negative attitude towards the patentability of human embryonic stem cells. The reason is mainly based on ethical considerations. However, with the continuous development of science and technology, the scope of the object protected by the traditional patent system is subject to the scope. Challenges. In the field of biotechnology, the rapid development of human embryonic stem cell technology and its great medical value have aroused great concern. Since the invention of human embryonic stem cells is excluded from patent protection, many new human embryonic stem cell technologies can not be protected by the special benefit system. The invention of human embryonic stem cells is the invention. With the development of human embryonic stem cells (embryonic stem cells), the patent protection of human embryonic stem cells is becoming more and more challenging. In practice, there have been some cases about the patentability of human embryonic stem cells. The emergence of these cases has also triggered a strong theoretical and practical controversy. The invention of the patentable problem of human embryonic stem cells.
This paper first introduces the basic knowledge of embryonic stem cells, and summarizes the obstacles to the invention of the patentability of human embryonic stem cells, and then reviews the status of the legal regulation of human embryonic stem cell research and the status of patent protection in order to observe the attitudes of countries to the research of human embryonic stem cells. The patentability of the invention of human embryonic stem cells is analyzed in two aspects: the patentable theme and the essential element of authorization. The feasible conclusion of the invention patent protection of human embryonic stem cells is drawn. Finally, the application of the existing patent system in China on the invention of human embryonic stem cells is analyzed and some relevant suggestions are put forward.

【學(xué)位授予單位】：華中科技大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2012
【分類號(hào)】：R329.2;D923.42

【參考文獻(xiàn)】

相關(guān)期刊論文 前2條

1 徐國棟;體外受精胎胚的法律地位研究[J];法制與社會(huì)發(fā)展;2005年05期

2 伍春艷,鄭友德;轉(zhuǎn)基因生物體的專利保護(hù)研究[J];山西大學(xué)學(xué)報(bào)(哲學(xué)社會(huì)科學(xué)版);2000年04期

本文編號(hào)：1877591